Table 2 |
|||||
|
List of alternative splicing events confirmed using rtPCR |
|||||
| Gene |
GenBank accession number (reference transcript*) |
GenBank accession number (variant transcript*) |
Alternative splicing event: change of mRNA transcript composition in disease state† |
Alternatively spliced region |
rtPCR p value |
|
|
|||||
| mTLE |
|||||
| CACNB1 |
NM_000723 |
NM_199247 |
NE: 65% ↑ variant/reference ratio |
INTRON 6 |
0.035 |
| CACNB4 |
NM_000726 |
AY054985 |
NE: 4.2x ↑ variant/reference ratio |
INTRON 2 |
0.027 |
| CLCN7 |
NM_001287 |
AK096963 |
IR: 65% ↓ variant/total ratio |
INTRON 18 |
<0.001 |
| FXYD6 |
NM_022003 |
BP372334 |
NE: 22% ↓ variant/reference ratio |
INTRON 1 |
<0.001 |
| GRIA1 |
NM_000827 |
A46050 |
NE: 62% ↓ variant/reference ratio |
INTRON 14 |
0.002 |
| KCNK1 |
NM_002245 |
AV733795 |
PIED: 13% ↓ variant/total ratio |
EXON 2 |
<0.001 |
| KCNQ2 |
NM_004518 |
AY358189 |
NE: 34% ↓ variant/total ratio |
INTRON 7 |
<0.001 |
| MCOLN1 |
NM_020533 |
CA489568 |
ASD: 47% ↑ variant/reference ratio |
EXON 7 |
<0.001 |
| AD |
|||||
| CACNA1G |
NM_018896 |
NM_198376 |
PIED: 67% ↓ variant/total ratio |
EXON 36 |
<0.001 |
| GABRA6 |
NM_000811 |
AK090735 |
IR: 30% ↓ variant/reference ratio |
INTRON 6 |
0.007 |
| GRIA1 |
NM_000827 |
A46050 |
NE: 2.5x ↑ variant/reference ratio |
INTRON 14 |
0.001 |
| KCNAB1 |
NM_172160 |
NM_172159 |
NE: 75% ↓ variant/reference ratio |
INTRON 1 |
0.004 |
| KCNN1 |
NM_002248 |
BM718136 |
ASD: 25% ↓ variant/reference ratio |
EXON 6 |
<0.001 |
| KCNN2 |
NM_021614 |
BG769522 |
ES: 85% ↓ variant/reference ratio |
EXON 3 |
0.002 |
| MCOLN1 |
NM_020533 |
CA489568 |
ASD: 19% ↑ variant/reference ratio |
EXON 7 |
0.016 |
|
|
|||||
|
*Reference transcript refers to traditionally spliced gene product, while the variant refers to the alternatively spliced mRNA transcript. †Splice array determined results were confirmed using quantitative rtPCR in a larger sample size (control (n = 28-29) versus mTLE neocortex (n = 43); control (n = 27) versus AD (n = 31) temporal cortex and cerebellum). ASA, alternative splice acceptor site; ASD, alternative splice donor site; ES, exon skipped; EsS, exons skipped; IR, intron retention; NE, novel exon; NEs, novel exons; PIED, partial internal exon deletion. |
|||||
|
Heinzen et al. Genome Biology 2007 8:R32 doi:10.1186/gb-2007-8-3-r32 |
|||||